Public release date: 16-May-2012 [ | E-mail | Share ] Contact: Dr. Continue reading
Category Archives: Molecular Medicine
Press Release
Foundation Medicine Inc.Posted on:17 May 12 Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genomic analysis to routine clinical care, today announced that new clinical data highlighting the companys comprehensive cancer genomic profile and next-generation sequencing approach in clinical oncology will be presented at the 2012 Annual Meeting of the American Society for Clinical Oncology (ASCO) being held June 1-5, 2012 in Chicago. The data to be presented at ASCO support Foundation Medicines deep sequencing approach to simultaneously detect all classes of genomic alterations across hundreds of genes known to be related to cancer, said Michael J Continue reading
Cancer Institute of New Jersey Aims to Advance Personalized Cancer Treatments Through 'Precision Medicine'
Newswise New Brunswick, N.J., May 15, 2012 With recent advancements in technology and biomedical informatics, a more personalized approach to prescribing cancer treatment and developing these therapies is preferred over one-size-fits-all methods. The Cancer Institute of New Jersey (CINJ) has been on the cutting-edge of this movement and is now launching a more concrete effort that is poised to change the way that molecular and genetic information is being used to diagnose and treat cancer an initiative known as precision medicine also known to many as personalized medicine Continue reading
CNIO scientists successfully test the first gene therapy against aging-associated decline
Public release date: 14-May-2012 [ | E-mail | Share ] Contact: Juan J. Gomez juanj.gomez@cnio.es 34-917-328-000-4060 Centro Nacional de Investigaciones Oncologicas (CNIO) A number of studies have shown that it is possible to lengthen the average life of individuals of many species, including mammals, by acting on specific genes. To date, however, this has meant altering the animals’ genes permanently from the embryonic stage an approach impracticable in humans. Continue reading
Pair of molecular biologists receive Albany Medical Center Prize
By Record Staff newsroom@troyrecord.com Twitter.com/troyrecord Molecular biologist Robert Roeder, left, and James Darnell Jr., right, will share the $500,000 Albany Medical Center Prize in Medicine and Biomedical Research for their pioneering research on how cells express their genetic information. (AP Photo) ALBANY Two molecular biologists who performed pioneering research on how cells express their genetic information were awarded the annual Albany Medical Center Prize in Medicine and Biomedical Research Continue reading
Two Molecular Biologists Get $500K Medical Prize
ALBANY, N.Y. Continue reading
2 molecular biologists from NYC to share $500K medical prize for pioneering research on cells
The Canadian Press – ONLINE EDITION By: The Associated Press 11/05/2012 1:10 PM | Comments: 0 Enlarge Image Molecular biologist James Darnell Jr., speaks after being awarded the Albany Medical Center Prize in Medicine and Biomedical Research in Albany, N.Y., on Friday, May 11, 2012. Continue reading
Lab21 Unveils New Molecular Analysis Services at Greenville Site
CAMBRIDGE, England–(BUSINESS WIRE)– Lab21, the global specialist in personalized medicine and clinical diagnostics, is pleased to announce that routine analysis of clinical samples has begun from Lab21 Inc.s new CLIA laboratory in Greenville, South Carolina. The first assays in the test menu include a new Human Papillomavirus (HPV) High Risk and HPV 16 and 18 Genotyping Service. Continue reading
2 molecular biologists share $500K medical prize
Home : Health : 2 molecular biologists share $500K medical prize The Associated Press Date: Friday May. 11, 2012 8:14 AM ET ALBANY, N.Y. Two molecular biologists are being awarded the annual Albany Medical Center Prize in Medicine and Biomedical Research. Continue reading
2 molecular biologists get $500K medical prize
Two molecular biologists have been awarded the annual Albany Medical Center Prize in Medicine and Biomedical Research. Continue reading
Genomics used to identify a molecular-based treatment for a viral skin cancer
ScienceDaily (May 9, 2012) Four years after they discovered the viral roots of a rare skin cancer, researchers at the University of Pittsburgh Cancer Institute (UPCI) and the School of Medicine have now identified a molecule activated by this virus that, in animal studies, could be targeted to selectively kill the tumor cells. Continue reading
Pitt team uses genomics to identify a molecular-based treatment for a viral skin cancer
Public release date: 9-May-2012 [ | E-mail | Share ] Contact: Anita Srikameswaran SrikamAV@upmc.edu 412-578-9193 University of Pittsburgh Schools of the Health Sciences PITTSBURGH, May 9 Four years after they discovered the viral roots of a rare skin cancer, researchers at the University of Pittsburgh Cancer Institute (UPCI) and the School of Medicine have now identified a molecule activated by this virus that, in animal studies, could be targeted to selectively kill the tumor cells. The treatment will soon be tested in patients. Merkel cell carcinoma (MCC), a skin cancer that is more common among seniors and those with weakened immune systems, could not be readily diagnosed at one time, and it still has a very poor prognosis, said Patrick S. Continue reading
NCKU student receives Graduate/Postdoctoral Travel Award from ASBMB
Published on May 10, 2012 at 1:48 AM Wan-Pei Su, a graduate student of Molecular Medicine at National Cheng Kung University (NCKU), southern Taiwan, has received a Graduate/Postdoctoral Travel Award from the American Society for Biochemistry and Molecular Biology (ASBMB) to attend the annual conference on Experimental Biology (EB) in San Diego in April 2012. NCKU President Hwung-Hweng Hwung congratulated Su and her advisor, Dr. Nan-Shan Chang, director of NCKU Institute of Molecular Medicine, for winning international recognition Continue reading
In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers …
NEW YORK, May 9, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p0849772/In-Vitro-Diagnostics-IVD-Market-Clinical-Chemistry-Immunoassays-Molecular-Diagnostics-Hematology-Analyzers–Microbiology-Culture–Global-Trends–Forecasts-to-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers & Microbiology Culture) Global Trends & Forecasts to 2016 The global in-vitro diagnostics (IVD) market was valued at $44 billion in 2011 and is expected to have a modest growth during the study period. The U.S. represented the biggest market for IVD equipments accounting for about a half of the total market. Continue reading
NCKU Student Wins Prestigious Award for Anti-Cancer Research
TAINAN, Taiwan–(BUSINESS WIRE)– Wan-Pei Su, a graduate student of Molecular Medicine at National Cheng Kung University (NCKU), southern Taiwan, has received a Graduate/Postdoctoral Travel Award from the American Society for Biochemistry and Molecular Biology (ASBMB) to attend the annual conference on Experimental Biology (EB) in San Diego in April 2012. NCKU President Hwung-Hweng Hwung congratulated Su and her advisor, Dr. Nan-Shan Chang, director of NCKU Institute of Molecular Medicine, for winning international recognition Continue reading
Penn State student Zachary Hostetler from Garnet Valley is being honored as a student marshal
Zachary Hostetler of Garnet Valley, Pennsylvania, is one of two students who will be honored as the student marshals for the Eberly College of Science during Penn State’s spring commencement ceremonies on 5 May, 2012 at the University Park campus. Hostetler’s faculty escort will be Song Tan, a professor in the Department of Biochemistry and Molecular Biology Continue reading
Researchers' discovery offers hope for cancer, heart disease miracle drugs
OTTAWA A team of University of Ottawa researchers has solved the mystery of how our bodies adapt to low-oxygen environments, raising the prospect that life-threatening conditions such as cancer, stroke and heart disease could someday be successfully treated using a simple, antibiotic-like drug. The teams findings were published Sunday in Nature, the worlds leading scientific journal. Its a tremendously important discovery in understanding how life without oxygen works, said Dr Continue reading
This Week in Experimental and Molecular Pathology
In Experimental and Molecular Pathology, researchers in China and the US report that IL-21R expression on CD8+ T-cells promotes their activation in coxsackievirus B3-induced myocarditis. The team infected C57Bl/6 and IL-21R knock-out mice with CVB3 and found that the IL-21RKO mice developed significantly less myocarditis than C57Bl/6 animals. “Numbers of CD8+IFN+ cells were decreased in IL-21RKO mice but numbers of either CD4+IFN+ or CD4+IL-4+ cells were not significantly different from C57Bl/6 animals indicating a selective effect of IL-21 signaling on the CD8+ T cell response,” the authors write. Continue reading
Cutting Edge Technology Coming To DMH
DECATUR, IL- Decatur Memorial Hospital is in the process of constructing a Center for Advanced Molecular Medicine. The center will allow DMH to improve the diagnosis of cancer, Alzheimer’s and heart disease Continue reading
Nanotechnology In Medicine: Huge Potential, But What Are The Risks?
Featured Article Main Category: Medical Devices / Diagnostics Also Included In: Cancer / Oncology;Biology / Biochemistry Article Date: 04 May 2012 – 11:00 PDT email to a friend printer friendly opinions Current Article Ratings: This article does not attempt to cover the whole field, but offers, by means of some examples, a few insights into how nanotechnology has the potential to change medicine, both in the research lab and clinically, while touching on some of the challenges and concerns that it raises. The ability to manipulate structures and properties at the nanoscale in medicine is like having a sub-microscopic lab bench on which you can handle cell components, viruses or pieces of DNA, using a range of tiny tools, robots and tubes. This creates a need for tools that help scientists experiment and develop such treatments Continue reading